The XRP price has dropped 2.3% in the last 24 hours to trade at $2.86 as 3.30 a.m. EST amid news that David Schwartz will [...]The XRP price has dropped 2.3% in the last 24 hours to trade at $2.86 as 3.30 a.m. EST amid news that David Schwartz will [...]

XRP Price Slumps 2.3% As Ripple CTO David Schwartz Announces Exit

3 min read

The XRP price has dropped 2.3% in the last 24 hours to trade at $2.86 as 3.30 a.m. EST amid news that David Schwartz will step down as Rippple’s Chief Technology Officer (CTO).

While he will no longer handle day-to-day responsibilities as CTO, Schwartz assured the XRP community that he is not leaving entirely. He intends to stay engaged and continue contributing to the ecosystem, reinforcing his long-standing commitment to Ripple and its community.

Schwartz’s ongoing involvement as a board member is expected to provide continuity and technical guidance. Ripple’s engineering is now led by Dennis Jarosch, who carries the task of advancing Ripple’s tech innovations.

Investors will watch closely for any new product announcements or partnerships that could boost the XRP price and adoption.

XRP Active Addresses Drop as Price Holds Steady

New data shows that activity on the XRP Ledger has slowed down even though XRP’s price is holding above $0.50. According to CryptoQuant, the number of active addresses has dropped to around 22,000 per day.

This is much lower than the spikes seen in late 2024 and early 2025, when daily active addresses went above 100,000.

Back then, XRP also rallied strongly, moving above $2.50. But in recent months, while network activity has cooled, XRP has stayed fairly stable in price.

This means that fewer retail users are active on the network, but larger or long-term investors may still be supporting the price.

The gap between low address activity and steady price performance suggests that XRP is being held more for investment than frequent transactions.

XRP Ledger Active Addresses Source: CryptoQuant

XRP Price Drops Amid Leadership Change

XRP price declined from recent highs, hitting a low near $2.81 before bouncing to around $2.86 in the last 24 hours. The coin is still above its important 200-day simple moving average (SMA) at $2.56, which acts as a strong support level and dampens deeper losses.

The 50-day SMA at $2.94 serves as resistance, meaning XRP needs to clear this to regain upward momentum.

XRP price

XRPUSDT Analysis Source: Tradingview

Looking at the chart, the XRP price is trading between key Fibonacci retracement levels from its recent peak near $3.66 to the low around $2.07. The price currently sits close to the 0.618 retracement level at $2.68, a common support zone during corrections.

Technical indicators reflect neutral market conditions. The Relative Strength Index (RSI) is near 46.49, suggesting no strong momentum either way. The MACD is slightly below the signal line but close to neutrality, signalling possible price consolidation.

The Average Directional Index (ADX) reads 14.88, indicating a weak trend, which means the market may be waiting for new catalysts.

If XRP breaks above the 50-day SMA at $2.94, the next resistance zone lies between $3.00 and $3.20. Surpassing this could trigger renewed buying and a test of higher levels near the $3.60 peak.

However, if the price falls below the 200-day SMA at $2.56, XRP might revisit lower supports near $2.41 and $2.07, risking further short-term selling.

XRP remains supported by key moving averages and Fibonacci levels, while technical indicators suggest a wait-and-see market.

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.5824
$1.5824$1.5824
-2.20%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29